SB 465
  • Introduced
    Jan 07, 2026
  • Passed Senate
  • Passed House
  • Became Law
SB 465
New Hampshire Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Title: classifying xylazine as a schedule III controlled drug.
Last Action See all actions
Senate • Mar 05, 2026: Committee Report: Ought to Pass with Amendment #2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8
Latest Bill Text See all bill texts
Introduced
Senate Calendar: No 8 CONSENT CALENDAR - JUDICIARY (None)
Position: 40

Summary

Comments on SB 465

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Mar 05, 2026 | Senate
    • Committee Report: Ought to Pass with Amendment #2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8
  • Feb 10, 2026 | Senate
    • Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A
  • Jan 07, 2026 | Senate
    • Introduced 01/07/2026 and Referred to Judiciary; SJ 1
Bill Texts
Documents
Sources